Maurizio Averna

Summary

Affiliation: University of Palermo
Country: Italy

Publications

  1. pmc Prothrombotic gene variants as risk factors of acute myocardial infarction in young women
    Rossella Tomaiuolo
    CEINGE Biotecnologie Avanzate, Via Gaetano Salvatore 486, Naples, 80145, Italy
    J Transl Med 10:235. 2012
  2. pmc Ezetimibe/simvastatin 10/20 mg versus rosuvastatin 10 mg in high-risk hypercholesterolemic patients stratified by prior statin treatment potency
    Margus Viigimaa
    Tallinn University of Technology, Technomedicum, Ehitajate St, 5, 19086 Tallinn, Estonia
    Lipids Health Dis 9:127. 2010
  3. doi request reprint Lipid-altering efficacy of switching to ezetimibe/simvastatin 10/20 mg versus rosuvastatin 10 mg in high-risk patients with and without metabolic syndrome
    Maurizio Averna
    Professor of Internal Medicine, Department of Clinical Medicine and Emerging Diseases, University of Palermo Medical School, Palermo, Italy
    Diab Vasc Dis Res 8:262-70. 2011
  4. doi request reprint Ezetimibe/simvastatin 10/20 mg versus simvastatin 40 mg in coronary heart disease patients
    Maurizio Averna
    Department of Clinical Medicine and Emerging Diseases, Policlinico Paolo Giaccone, University of Palermo, Palermo, Italy
    J Clin Lipidol 4:272-8. 2010
  5. doi request reprint Clinical, pathologic, and genetic features of massive soft tissue neurofibromas in a Sicilian patient
    Maria Rita Bongiorno
    Department of Dermatology, University of Palermo, Palermo, Italy
    Dermatol Ther 21:S21-5. 2008
  6. doi request reprint Clinical utility of novel biomarkers for cardiovascular disease risk stratification
    Maurizio Averna
    Department of Internal Medicine and Medical Specialties DIMIS, University of Palermo, Palermo, Italy
    Intern Emerg Med 7:263-70. 2012
  7. doi request reprint Plasma non-cholesterol sterols: a useful diagnostic tool in pediatric hypercholesterolemia
    Davide Noto
    Department of Clinical Medicine and Emerging Diseases, University of Palermo, Palermo I90127, Italy
    Pediatr Res 67:200-4. 2010
  8. doi request reprint Familial hypobetalipoproteinemia due to apolipoprotein B R463W mutation causes intestinal fat accumulation and low postprandial lipemia
    Davide Noto
    Department of Clinical Medicine and Emerging Diseases, University of Palermo, Italy
    Atherosclerosis 206:193-8. 2009
  9. ncbi request reprint Association between HFE mutations and acute myocardial infarction: a study in patients from Northern and Southern Italy
    Giuseppina Candore
    Gruppo di Studio sull Immunosenescenza, Dipartimento di Biopatologia e Metodologie Biomediche, Universita di Palermo, Palermo, Italy
    Blood Cells Mol Dis 31:57-62. 2003
  10. ncbi request reprint Differential apolipoprotein(a) isoform expression in heterozygosity is an independent contributor to lipoprotein(a) levels variability
    Davide Noto
    Department of Internal Medicine and Geriatrics, University of Palermo, Palermo, Italy
    Clin Chim Acta 328:91-7. 2003

Collaborators

  • Margus Viigimaa
  • Marcello Arca
  • Giuseppina Candore
  • Vilma Mantovani
  • Davide Noto
  • Angelo B Cefalù
  • Rossella Tomaiuolo
  • Mariangela Minà
  • Francesca Fayer
  • Maria Rita Bongiorno
  • Carlo M Barbagallo
  • Sandro Quaranta
  • Federica Zarrilli
  • Giuseppe Castaldo
  • Rosanna Di Fiore
  • Pierpaolo Di Micco
  • Chiara Bellia
  • Antonietta Caruso
  • Marcello Ciaccio
  • Giacoma Barraco
  • Eliana Martino
  • Francesco Martino
  • Anna Montali
  • Antonino Tuttolomondo
  • Alessandra Cannizzaro
  • Antonio Pinto
  • Carmelo Sciume
  • Vincenza Valenti
  • Giuseppe Licata
  • Mario Aricò
  • Giovanni Emmanuele
  • Manfredi Rizzo
  • Giuseppina Marino
  • Antonio Pace
  • Alberto Notarbartolo
  • Salvatore Travali

Detail Information

Publications10

  1. pmc Prothrombotic gene variants as risk factors of acute myocardial infarction in young women
    Rossella Tomaiuolo
    CEINGE Biotecnologie Avanzate, Via Gaetano Salvatore 486, Naples, 80145, Italy
    J Transl Med 10:235. 2012
    ..Acute myocardial infarction (AMI) in young women represent an extreme phenotype associated with a higher mortality compared with similarly aged men. Prothrombotic gene variants could play a role as risk factors for AMI at young age...
  2. pmc Ezetimibe/simvastatin 10/20 mg versus rosuvastatin 10 mg in high-risk hypercholesterolemic patients stratified by prior statin treatment potency
    Margus Viigimaa
    Tallinn University of Technology, Technomedicum, Ehitajate St, 5, 19086 Tallinn, Estonia
    Lipids Health Dis 9:127. 2010
    ..This post-hoc analysis compared the lipid-altering efficacy of Ezetimibe/Simvastatin 10/20 mg (EZ/Simva) versus Rosuvastatin 10 mg (Rosuva) in patients stratified by statin potency/dose prior to randomization...
  3. doi request reprint Lipid-altering efficacy of switching to ezetimibe/simvastatin 10/20 mg versus rosuvastatin 10 mg in high-risk patients with and without metabolic syndrome
    Maurizio Averna
    Professor of Internal Medicine, Department of Clinical Medicine and Emerging Diseases, University of Palermo Medical School, Palermo, Italy
    Diab Vasc Dis Res 8:262-70. 2011
    ..In this post-hoc analysis of high-risk hypercholesterolaemic patients the lipid-reducing effects of ezetimibe/simvastatin or rosuvastatin were not altered significantly by the presence of MetS...
  4. doi request reprint Ezetimibe/simvastatin 10/20 mg versus simvastatin 40 mg in coronary heart disease patients
    Maurizio Averna
    Department of Clinical Medicine and Emerging Diseases, Policlinico Paolo Giaccone, University of Palermo, Palermo, Italy
    J Clin Lipidol 4:272-8. 2010
    ..Reducing low-density lipoprotein cholesterol (LDL-C) is the primary goal of therapy in patients with hypercholesterolemia and coronary heart disease (CHD)...
  5. doi request reprint Clinical, pathologic, and genetic features of massive soft tissue neurofibromas in a Sicilian patient
    Maria Rita Bongiorno
    Department of Dermatology, University of Palermo, Palermo, Italy
    Dermatol Ther 21:S21-5. 2008
    ..Among these we identified two heterozygous frameshift mutations in exon 19 (c.2480delA) and a novel mutation in exon 21 (c.2632delC). Ten novel nonsynonymous missense variations were also identified in this patient...
  6. doi request reprint Clinical utility of novel biomarkers for cardiovascular disease risk stratification
    Maurizio Averna
    Department of Internal Medicine and Medical Specialties DIMIS, University of Palermo, Palermo, Italy
    Intern Emerg Med 7:263-70. 2012
    ..Only few of them had a significant improvement over the predictive models. In this paper, the most investigated biomarkers will be discussed and the evidence of their use as predictors of CV will be questioned...
  7. doi request reprint Plasma non-cholesterol sterols: a useful diagnostic tool in pediatric hypercholesterolemia
    Davide Noto
    Department of Clinical Medicine and Emerging Diseases, University of Palermo, Palermo I90127, Italy
    Pediatr Res 67:200-4. 2010
    ..NCS improve the detection of ADH in pediatric patients, whereas FCHL diagnosis is not improved...
  8. doi request reprint Familial hypobetalipoproteinemia due to apolipoprotein B R463W mutation causes intestinal fat accumulation and low postprandial lipemia
    Davide Noto
    Department of Clinical Medicine and Emerging Diseases, University of Palermo, Italy
    Atherosclerosis 206:193-8. 2009
    ....
  9. ncbi request reprint Association between HFE mutations and acute myocardial infarction: a study in patients from Northern and Southern Italy
    Giuseppina Candore
    Gruppo di Studio sull Immunosenescenza, Dipartimento di Biopatologia e Metodologie Biomediche, Universita di Palermo, Palermo, Italy
    Blood Cells Mol Dis 31:57-62. 2003
    ..Thus, our study, performed in two samples of genetically homogeneous patients and controls, does not support the suggestion that HFE mutations may be associated with acute myocardial infarction in susceptible individuals...
  10. ncbi request reprint Differential apolipoprotein(a) isoform expression in heterozygosity is an independent contributor to lipoprotein(a) levels variability
    Davide Noto
    Department of Internal Medicine and Geriatrics, University of Palermo, Palermo, Italy
    Clin Chim Acta 328:91-7. 2003
    ..Lipoprotein(a) levels, apolipoprotein(a) isoforms identification and expression, and the correlation with other lipo-apolipoprotein parameters have been investigated in 628 subjects >18 years of age...